ATR
$0.35
+$0.02+6.72%
27 November 2024
Summary:
Inhibikase Therapeutics average true range is currently $0.35, with a rise of +$0.02 (+6.72%) during the most recent trading day. Over the past year, it has increased by +$0.26 (+282.24%).IKT ATR Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT ATR Performance
| PeriodPeriod | ATRATR | PricePrice | 200-day SMA200-day SMA | SPXSPX |
|---|---|---|---|---|
| todaytoday | +6.7% | +11.6% | +0.1% | -0.4% |
| 1 m1 month | +37.5% | +7.3% | +0.5% | +3.3% |
| 3 m3 months | +115.5% | +85.7% | +4.7% | +6.6% |
| 6 m6 months | +90.6% | +36.8% | +4.0% | +13.1% |
| ytdytd | +200.7% | +109.7% | -27.3% | +25.8% |
| 1 y1 year | +282.2% | +198.8% | -36.6% | +31.8% |
| 5 y5 years | - | - | - | +90.2% |
IKT ATR High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $0.39 | -10.4% | $0.24 | -32.0% |
| 3 m | 3 months | $0.39 | -10.4% | $0.09 | -75.6% |
| 6 m | 6 months | $0.39 | -10.4% | $0.09 | -75.6% |
| 1 y | 1 year | $0.43 | -18.0% | $0.09 | -75.6% |
| 3 y | 3 years | $1.10 | -68.0% | $0.09 | -75.6% |
| 5 y | 5 years | $14.94 | -97.7% | $0.09 | -75.6% |
| alltime | all time | $14.94 | -97.7% | $0.09 | -75.6% |
Inhibikase Therapeutics ATR History
| Date | Value |
|---|---|
| 2024 | $0.34(+180.3%) |
| 2023 | $0.12(-68.3%) |
| Date | Value |
|---|---|
| 2022 | $0.38(-43.9%) |
| 2021 | $0.69(-94.3%) |
| 2020 | $12.13 |
FAQ
- What is Inhibikase Therapeutics average true range?
- What is the all time high ATR for Inhibikase Therapeutics?
- What is IKT average true range year-to-date change?
- What is Inhibikase Therapeutics ATR year-on-year change?
What is Inhibikase Therapeutics average true range?
The current ATR of IKT is $0.35
What is the all time high ATR for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high average true range is $14.94
What is IKT average true range year-to-date change?
Inhibikase Therapeutics average true range has changed by +$0.23 (+200.69%) since the beginning of the year
What is Inhibikase Therapeutics ATR year-on-year change?
Over the past year, IKT average true range has changed by +$0.26 (+282.24%)